COFEPRIS-2021-0034-V434
Major variation for application COFEPRIS-2021-0034. Major variation: Formulation Change for Glucovantib — major revision
Variation Number
COFEPRIS-2021-0034-V434
Type
Major
Application
Change
Status
Overdue
Fee
€44,967
Submitted
2024-05-30
Approved
—
Description
Major variation: Formulation Change for Glucovantib — major revision